Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: S and L...

correction ease

in response to by
posted on Dec 08, 2006 04:03AM
Last stated OS is 384 million in the same filing that PTSC said it had a lack of controls over how many shares it was giving away to S & L.

The Dutton analyst is basing his assumptions on 400 million shares OS.


Share
New Message
Please login to post a reply